These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 118957)

  • 21. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergic activity of beta-lactamines and aminoglycosides vs. bacterial strains treated with sub-MIC concentrations.
    Gismondo MR; Romeo MA; Pappalardo C; Puglisi G; Leonardi R
    Chemioterapia; 1984 Jun; 3(3):175-7. PubMed ID: 6529773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens.
    Gombert ME; Aulicino TM
    J Antimicrob Chemother; 1986 Mar; 17(3):323-6. PubMed ID: 3700292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptogramins. A unique class of antibiotics.
    Pechère JC
    Drugs; 1996; 51 Suppl 1():13-9. PubMed ID: 8724812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and epidemiology of resistance to virginiamycin and streptogramins.
    Thal LA; Zervos MJ
    J Antimicrob Chemother; 1999 Feb; 43(2):171-6. PubMed ID: 11252321
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrolide antibiotics M-4365 produced by Micromonospora. III. In vitro antimicrobial activity of antibiotic M-4365G2 (de-epoxy rosamicin).
    Yamaguchi T; Hayasaka H; Yoshida H; Matsushita T; Yamabe A; Ohshima S
    J Antibiot (Tokyo); 1978 May; 31(5):433-40. PubMed ID: 27495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
    Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
    Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics for bovine mycoplasmas.
    Hamdy AH; Miller CC
    J Dairy Sci; 1971 Oct; 54(10):1541-4. PubMed ID: 5114023
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium.
    Annadurai S; Guha-Thakurta A; Sa B; Dastidar SG; Ray R; Chakrabarty AN
    J Chemother; 2002 Feb; 14(1):47-53. PubMed ID: 11892899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
    Weber P; Dubois S; Boussougant Y
    J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in macrocyclic peptide-based antibiotics.
    Luther A; Bisang C; Obrecht D
    Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
    Cocito C
    Microbiol Rev; 1979 Jun; 43(2):145-92. PubMed ID: 117294
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of the biosynthetic gene cluster and regulatory cascade for the synergistic antibacterial antibiotics griseoviridin and viridogrisein in Streptomyces griseoviridis.
    Xie Y; Wang B; Liu J; Zhou J; Ma J; Huang H; Ju J
    Chembiochem; 2012 Dec; 13(18):2745-57. PubMed ID: 23161816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mode of action of antibiotics on gram-negative bacilli.
    Lorian V
    Arch Intern Med; 1971 Oct; 128(4):623-32. PubMed ID: 5111670
    [No Abstract]   [Full Text] [Related]  

  • 37. A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.
    Almaaytah A; Farajallah A; Abualhaijaa A; Al-Balas Q
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30004427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains.
    Mazumdar K; Dutta NK; Kumar KA; Dastidar SG
    Biol Pharm Bull; 2005 Apr; 28(4):713-7. PubMed ID: 15802815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.